$KPRX 8-K SEC Filings

Filed On	Filing
29 Oct 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure Date of report (Date of earliest event reported): October 23, 2026
08 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure Kiara Pharmaceuticals, Inc. (the "Company'') is pleased to offer you employment with a start date of September 1, 2026 (the "Start Date"). Your role shall be to serve as Executive Vice President, Head of Clinical Development and Regulato...
19 Aug 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
07 Aug 2026	8-K: Results of Operations and Financial Condition
18 Jun 2026	8-K: Regulation FD Disclosure
11 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
08 May 2026	8-K: Results of Operations and Financial Condition
07 Apr 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
02 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
25 Mar 2026	8-K: Results of Operations and Financial Condition
07 Nov 2025	8-K: Results of Operations and Financial Condition
13 Aug 2025	8-K: Regulation FD Disclosure
08 Aug 2025	8-K: Results of Operations and Financial Condition
04 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
03 Jun 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
09 May 2025	8-K: Results of Operations and Financial Condition
25 Mar 2025	8-K: Results of Operations and Financial Condition
15 Jan 2025	8-K: Departure/Election of Directors or Officers; Compensation
08 Nov 2024	8-K: Results of Operations and Financial Condition
29 Oct 2024	8-K: Regulation FD Disclosure

Comments